MIRO — Miromatrix Medical Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $92.95m
- $77.29m
- $0.95m
Annual cashflow statement for Miromatrix Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -4.05 | -10.3 | -14.7 | -30 |
| Depreciation | ||||
| Non-Cash Items | -4.34 | 1.04 | -1.75 | 1.08 |
| Discontinued Operations | ||||
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.284 | 1.06 | 1.44 | 1.09 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -8.32 | -8.04 | -14.8 | -26.7 |
| Capital Expenditures | -0.101 | -0.123 | -3.38 | -1.06 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 10.5 | 3 | 2 | -20 |
| Sale of Business | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | 10.4 | 2.88 | -1.38 | -21.1 |
| Financing Cash Flow Items | — | — | — | -0.236 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.312 | 6.36 | 65.4 | 0.168 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2.35 | 1.19 | 49.2 | -47.6 |